SCHEMBL25748750

SCHEMBL25748750

CCN(CC)C(=O)C(=O)c1c[nH]c2ccc(F)c(F)c12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 1/20 0.44
▸ HTR7 P34969 3/20 0.41
▸ HTR6 P50406 3/20 0.41
▸ HTR2A P28223 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ HTR1A P08908 2/20 0.38
▸ PRKAB2 O43741 3/20 0.36
▸ PRKAG1 P54619 3/20 0.36
▸ PRKAA2 P54646 3/20 0.36
▸ PRKAA1 Q13131 3/20 0.36
▸ PRKAG3 Q9UGI9 3/20 0.36
▸ PRKAG2 Q9UGJ0 3/20 0.36
▸ PRKAB1 Q9Y478 3/20 0.36
▸ MC4R P32245 2/20 0.36
▸ MC5R P33032 2/20 0.36
▸ MC3R P41968 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ HTR1D P28221 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29206556 0.92 GPR84 (0.40) GPR84HTR7HTR6HTR2AHTR1A
SCHEMBL25435471 0.88 GPR84 (0.43) GPR84HTR7HTR6HTR2AHTR1A
SCHEMBL25748562 0.85 HTR1A (0.48) HTR7HTR6SMN1; SMN2HTR1AALDH1A1
SCHEMBL29206558 0.84 HTR2A (0.44) GPR84HTR7HTR6HTR2ASMN1; SMN2
SCHEMBL25748755 0.81 GPR84 (0.41) GPR84HTR7HTR6HTR2AHTR1A
SCHEMBL25423216 0.80 GPR84 (0.40) GPR84HTR7HTR6HTR2AHTR1A
SCHEMBL30877217 0.78 GPR84 (0.46) GPR84HTR7HTR6HTR2AHTR1A
SCHEMBL25241237 0.77 GPR84 (0.47) GPR84HTR7HTR6HTR2AHTR1A
SCHEMBL25438497 0.75 ALDH1A1 (0.39) HTR6SMN1; SMN2ALDH1A1RAB9AHTR1D
SCHEMBL16597465 0.75 GPR84 (0.51) GPR84HTR6HTR2APRKAB2PRKAG1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250101038-A1 COMPOUNDS Psylo Pty Ltd (AU) 2025-03-27 — — US disclosed
EP-4452937-A1 COMPOUNDS Psylo Pty Ltd (AU) 2024-10-30 — — EP disclosed
CN-118715204-A Compounds of formula (I) 普赛洛私人有限公司 2024-09-27 — — CN disclosed
WO-2023115166-A1 COMPOUNDS Psylo Pty Ltd (AU) 2023-06-29 — — WO disclosed
WO-2023115166-A1 COMPOUNDS Psylo Pty Ltd (AU) 2023-06-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250101038-A1 COMPOUNDS NLN, SLC18A2, PYGB GPR84 3280/4885HTR7 192/4885HTR6 54/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback